Ambagon Therapeutics Inc.

Biotechnology company · Eindhoven, North Brabant, Netherlands

Ambagon Therapeutics Inc. is a biotechnology company headquartered in Eindhoven, North Brabant, Netherlands. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Ambagon Therapeutics at a glance

Typebiotechnology company

HeadquartersEindhoven, North Brabant, Netherlands

Earliest incorporation on record2020

SEC CIK1819934

What does Ambagon Therapeutics do?

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $5 million sold (2025).

Frequently asked questions about Ambagon Therapeutics

Where is Ambagon Therapeutics headquartered?

Ambagon Therapeutics Inc. is headquartered in Eindhoven, North Brabant, Netherlands.

What does Ambagon Therapeutics do?

Ambagon Therapeutics Inc. is a biotechnology company.

When was Ambagon Therapeutics founded?

The earliest incorporation on record for Ambagon Therapeutics Inc. is in 2020, according to public company registers.

Similar companies

Kiadis Pharma N.V.Amsterdam, North Holland, Netherlands
Escalier Biosciences B.V.Nijmegen, Gelderland, Netherlands
Qiagen N.V.Venlo, Limburg, Netherlands

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences